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Candida glabrata is the second most prevalent yeast in fungal infec-
tions, especially in immunocompromised and/or hospitalized patients.
The azole resistance within this species is very well-known and
results in a low therapeutic response of C. glabrata infections, particu-
larly when associated with biofilms. So, the main goal of this work
was to understand the different efficacies of two azoles against C.
glabrata biofilms: fluconazole (Flu), a long time used drug, and
voriconazole (Vcz), a recent drug used only in hospitals.
Antifungal (Flu and Vcz) susceptibilities were determined in pre-
formed 24-h-biofilms of different strains of C. glabrata (clinical isolates
and a reference strain). The ERG genes expression profiles of C. glab-
rata biofilms cells were determined. Additionally biofilms’ matrices
composition and the retention of the two azoles within the biofilm
matrix were evaluated.
The results showed that C. glabrata biofilms are more susceptible to
Vcz than Flu. Quantitative Real-Time-PCR results revealed an overex-
pression of the three ERG genes in the presence of both azoles. How-
ever, the ERG expression was more dependent on the strain than on
the agent. The matrix content was analyzed following biofilm expo-
sure to antifungal agents and it was noticed a decrease in proteins,
an increase in carbohydrates (also b 1,3-glucans) and ergosterol was
also found. A further evaluation was made with the determination of
the concentration of the agents diffusing through the biofilm, which
showed a remarkable difference between the two drugs, with Vcz
reaching more the cells than Flu, which could explain the differences
in biofilms susceptibilities.
To conclude, this study showed that the better performance of Vcz
in C. glabrata biofilms maybe due to its smaller molecule and there-
fore to its better absorption within the biofilm.
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